IDEAS home Printed from
   My bibliography  Save this article

Performance of European Member States in biotechnology


  • Thomas Reiss
  • Sibylle Hinze
  • Iciar Dominguez Lacasa


Despite an increasing policy interest in biotechnology in Europe, there is a lack of internationally comparable data on national performance in biotechnology. This paper presents a performance analysis of 14 Member States using science technology and economic indicators. A strong relationship between scientific and commercial performance was found. Four performance clusters were identified: the best-performing countries Denmark, Sweden and Finland; the second-best performers The Netherlands, the United Kingdom, Belgium and Germany; cluster three with Austria, France and Ireland, performing below the European median performance value, and the Mediterranean countries Italy, Spain, Portugal and Greece performing weakly as measured by all indicators. Copyright , Beech Tree Publishing.

Suggested Citation

  • Thomas Reiss & Sibylle Hinze & Iciar Dominguez Lacasa, 2004. "Performance of European Member States in biotechnology," Science and Public Policy, Oxford University Press, vol. 31(5), pages 344-358, October.
  • Handle: RePEc:oup:scippl:v:31:y:2004:i:5:p:344-358

    Download full text from publisher

    File URL:
    Download Restriction: Access to full text is restricted to subscribers.

    As the access to this document is restricted, you may want to search for a different version of it.


    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.

    Cited by:

    1. Tomasz Mroczkowski, 2014. "From Breakthrough to Incremental Innovation Leadership: Lessons from Germany," Journal of the Knowledge Economy, Springer;Portland International Center for Management of Engineering and Technology (PICMET), vol. 5(2), pages 409-426, June.
    2. Chung, Chao-chen, 2013. "Government, policy-making and the development of innovation system: The cases of Taiwanese pharmaceutical biotechnology policies (2000–2008)," Research Policy, Elsevier, vol. 42(5), pages 1053-1071.

    More about this item


    Access and download statistics


    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:oup:scippl:v:31:y:2004:i:5:p:344-358. See general information about how to correct material in RePEc.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Oxford University Press) or (Christopher F. Baum). General contact details of provider: .

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service hosted by the Research Division of the Federal Reserve Bank of St. Louis . RePEc uses bibliographic data supplied by the respective publishers.